Medical Director, Cardiometabolic Research Institute, Texas Medical Center
Richard Kones MD began as a mathematically inclined chemical engineer, and then attended NYU School of Medicine. Inspired by a mentor in the Physiology department, he conducted independent research studying aldosterone with a novel technique, and became a full member of the New York Academy of Sciences while still in medical school. He completed training in New York, continued a NIH Fellowship in cardiology at Tulane University School of Medicine, and worked at the Charity Hospital and Veterans Administration Hospital in New Orleans.
He returned to New York Medical College to continue researching actions of inotropic agents, myocardial function, preservation of ischemic myocardium, and cardiogenic shock, eventually relocating in Texas. An avid supporter of applications of biochemistry and physiology, he continued teaching and publishing, emphasizing translational research. In addition to presentations, lectures, has mentored medical students and house staff at several medical schools and affiliated hospitals. His interests turned to the role pathological signaling plays in the pathogenesis of atherothrombosis, especially the interaction of inflammatory mechanisms, endothelial dysfunction, mitochondrial involvement in disease, lipid metabolism, metabolic syndrome and related evidence-based interventions to improve clinical outcomes.
Fundamental mechanisms and molecular and cellular cardiology have been central to his work. A current project is a comparison of the use of different methods of revascularization with respect to guidelines and outcomes. During the course of his academic career he has received several scholarships, awards, and grants. His work includes publications in peer-reviewed medical journals, books, presentations, and lectures. He serves on a number of committees in various medical organizations, peer reviews for over 130 medical journals, and volunteers for the mentoring programs in the American Society for Clinical Pharmacology and Therapeutics and American Heart Association. Over the years Dr. Kones’ biography has appeared in a number of editions of Who’s Who and other biographical registries. At its inception, he was appointed one of the founding editors of Medpedia online, a collaborative educational project among several medical schools, and served as a Board Member of the Committees on Cardiovascular Disease, Internal Medicine, and Nutrition of the Medpedia project. Currently he is Editor-in-Chief of Research Reports in Clinical Cardiology and sits on the Editorial Boards of other journals. Some publications may be viewed at http://www.ncbi.nlm.nih.gov/pubmed/?term=kones+r
Dr Kones has peer-reviewed, repeatedly, for over 130 journals during his career.
He is a Fellow of the American Heart Association, European Heart Association, Royal Society of Medicine, Royal Society of Public Health, Fellow of the New York Cardiological Society, now merged with the New York Chapter of the American College of Cardiology, and a Founding Fellow of the American Geriatrics Society, and the American College of Pharmacology. He is a member of the ESC Council for Cardiology Practice, European Heart Rhythm Association, Acute Cardiovascular Care Association, the Heart Rhythm Society, and the Heart Failure Association. Dr. Kones is an emeritus member of the American Physiological Society, a member of The Physiological Society in London, as well as the International Union of the Physiological Sciences. He is also a member of several Councils in the American Heart Association, a member of the American Society for Clinical Pharmacology and Therapeutics, and a Fellow in both the American College of Angiology and International College of Angiology. His other affiliations include the Society for Critical Care Medicine, European Atherosclerosis Society, International Atherosclerosis Society, American Society for Hypertension, National Lipid Association, American Association of Cardiovascular and Pulmonary Rehabilitation, American Society for Preventive Cardiology, Society of Atherosclerosis Imaging and Prevention, International Society for Heart Research, Heart Failure Society of America, American Diabetes Association, Endocrine Society, American Thoracic Society, Inflammation Research Association, and the Metabolic Syndrome Institute. He has also been a long-standing active member of the French Society of Cardiology and other notable scientific organizations and working groups.
The American Physiological Society has recognized Dr Kones for sustained years of active service, as did the American College of Sports Medicine with a commemorative award. He has volunteered on mentorship panels of the AHA, Endocrine Society and the American Society for Clinical Pharmacology and Therapeutics. Dr Kones is a supporter of, and volunteer in, the American Heart Association’s Advocacy Program, among other health advocacy groups (www.linkedin.com/in/richard-kones-md-faha-fesc-frsm-fccp-frsph-50032617). An competitive tennis player in youth, he remains an exercise and healthy lifestyle enthusiast.
Components of cardiovascular risk, inflammation, mechanisms, achieving pharmacological goals, and optimum outcomes.